Substance use and other correlates of HIV infection among transwomen and men who have sex with men in Perú: Implications for targeted HIV prevention strategies for transwomen.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
06
2022
accepted:
10
12
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
Characterization of HIV risk factors among transwomen and men who have sex with men (MSM) should be assessed separately and independently. However, due to several constraints, these populations continue to be conflated in clinical research and data. There are limited datasets globally powered to make such comparisons. The study aimed to use one of the largest surveys of transwomen and MSM in Latin America to determine differences in HIV risk and related correlates between the two populations. Secondary data analysis was completed using a cross-sectional biobehavioral survey of 4413 MSM and 714 transwomen living in Perú. Chi Square analysis of selected HIV correlates was conducted to examine differences between transwomen and MSM. Additionally, stratified binary logistic regression was used to split data for further comparative analyses of correlates associated with transwomen and MSM separately. HIV prevalence among transwomen was two-fold greater than among MSM (14.9% vs. 7.0%, p<0.001). Transwomen had a higher prevalence of most HIV risk factors assessed, including presence of alcohol dependence (16.4% vs. 19.0%; p < .001) and drug use in the past 3 months (17.0% vs. 14.9%). MSM were more likely to use marijuana (68.0% vs. 50.0%, p < .001), and transwomen were more likely to engage in inhaled cocaine use (70.0% vs. 51.1%, p < .001). The regression exposed differences in correlates driving sub-epidemics in transwomen vs. MSM, with a trend of substance use increasing HIV risk for transwomen only. Transwomen were more likely to be HIV-infected and had different risk factors from MSM. Targeted prevention strategies are needed for transwomen that are at highest risk. Additionally, further research is needed to determine if these observations in Perú regarding substance use patterns and the role of substance use in HIV risk relate to other trans populations globally.
Identifiants
pubmed: 36962933
doi: 10.1371/journal.pgph.0001464
pii: PGPH-D-22-00965
pmc: PMC10022005
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0001464Informations de copyright
Copyright: © 2023 Cyrus et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Trop Med Int Health. 2007 Feb;12(2):174-82
pubmed: 17300623
Lancet. 2015 Jan 17;385(9964):274-86
pubmed: 25059941
PLoS One. 2011;6(9):e24295
pubmed: 21931673
J Int AIDS Soc. 2016 Jul 17;19(3 Suppl 2):20799
pubmed: 27431470
J Int AIDS Soc. 2016 Jul 17;19(3 Suppl 2):20790
pubmed: 27431469
PLoS One. 2013 Aug 06;8(8):e69966
pubmed: 23936364
Drug Alcohol Depend. 2016 Apr 1;161:147-54
pubmed: 26896169
Sex Transm Dis. 2020 Aug;47(8):549-555
pubmed: 32541611
Drug Alcohol Rev. 2014 May;33(3):287-95
pubmed: 24628655
Alcohol Clin Exp Res. 1997 Jun;21(4):613-9
pubmed: 9194913
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
BMJ Open. 2013 Jul 24;3(7):
pubmed: 23883879
Arch Sex Behav. 2014 Nov;43(8):1503-14
pubmed: 25030120
Sex Transm Dis. 2017 Mar;44(3):143-148
pubmed: 28178111
J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S96-9
pubmed: 21857306
J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):522-526
pubmed: 30664074
J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):567-75
pubmed: 25950207
J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):93-9
pubmed: 19295339
AIDS Behav. 2008 Jan;12(1):18-26
pubmed: 17705095
J Acquir Immune Defic Syndr. 2009 May 1;51 Suppl 1:S47-51
pubmed: 19384102
AIDS. 2004 Oct 21;18(15):2075-9
pubmed: 15577629
Sex Transm Infect. 2007 Dec;83(7):534-40
pubmed: 17942575